Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mushtaq, Muhammad Umair  [Clear All Filters]
2024
Shahzad M, Iqbal Q, Tariq E, Ammad-Ud-Din M, Butt A, Mushtaq AHassan, Ali F, Chaudhary SGull, Anwar I, Gonzalez-Lugo JD, et al. Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in TP53-mutated Myelodysplastic syndrome: A Systematic Review and Meta-Analysis. Crit Rev Oncol Hematol. 2024:104310.
Mushtaq MUmair, Shahzad M, Amin MK, Lutfi F, DeJarnette S, Al-Ramahi JS, Li K, Ahmed N, Bansal R, Abdelhakim H, et al. Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation. Leuk Lymphoma. 2024:1-10.
McGuirk M, Shahzad M, Amin MKashif, Khan MAtif, Bellman P, Mudaranthakam DPal, DeJarnette S, Lutfi F, Ahmed N, Bansal R, et al. Predictors of cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: Insights from a real-world experience. Transpl Immunol. 2024:102039.
Bellman P, Gonzalez-Lugo JD, Shahzad M, Amin MKashif, Khalid MFareed, Suleman N, Ahmed N, Singh AK, Yacoub A, Zhang D, et al. Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review. Front Oncol. 2024;14:1383730.
Shahzad M, Khalid MFareed, Amin MKashif, Ammad-Ud-Din M, Ilyas U, Mushtaq AH, Butt A, Anwar I, Chaudhary SGull, Ahmed N, et al. Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review. Hematol Oncol Stem Cell Ther. 2024;17(2):88-94.
2023
Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SGull, Ahmed N, Bansal R, et al. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analys. Clin Lymphoma Myeloma Leuk. 2023.
Ahmed N, Wesson W, Mushtaq MUmair, Porter DL, Nasta SD, Brower J, Bachanova V, Hu M, Nastoupil LJ, Oluwole OO, et al. Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel (tisa-cel) Recipients for B Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2023.
Din MAmmad Ud, Jaan A, Shahzad M, Liaqat H, McGuirk J, Mushtaq MUmair. Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection. Transpl Infect Dis. 2023:e14066.
2022
Shahzad M, Chaudhary SGull, Zafar MU, Hassan MA, Hussain A, Ali F, Anwar I, Ahmed M, Ahmed N, Khurana S, et al. Impact of COVID-19 in Hematopoietic stem cell transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2022.
2021
Shahzad M, Chaudhary SGull, Basit A, Thellman C, Rodriguez L, Abhyankar SH, McGuirk JP, Mushtaq MUmair. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review. Transpl Immunol. 2021:101520.
Mushtaq MUmair, Shahzad M, Chaudhary SGull, Luder M, Ahmed N, Abdelhakim H, Bansal R, Balusu R, DeJarnette S, Divine C, et al. Impact of SARS-CoV-2 in hematopoietic stem cell transplant and CAR-T cell therapy recipients. Transplant Cell Ther. 2021.
Shahzad M, Siddiqui RS, Anwar I, Chaudhary SGull, Ali T, Naseem M, Ahmed TF, Ahmed Z, Khurana S, Ahmed N, et al. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther. 2021.